Genetic answers for inherited retinal disease. Built for India.
DrSeq IRD is Nucleome’s exome-based genetic test for inherited retinal diseases. It combines a proven short-read sequencing workflow with AI-based variant–phenotype correlation and trio analysis, to give Indian patients and families a clearer genetic diagnosis.
Three challenges stand in the way of an IRD diagnosis in India
Inherited retinal diseases (IRDs) damage the light-sensing tissue of the eye and can lead to progressive vision loss. For many families in India, an accurate genetic diagnosis remains difficult.
- Missed medical intervention — treatment often depends on knowing the causative gene
- Exclusion from clinical trials — which usually require a confirmed molecular diagnosis
- Elevated family-planning risks — families cannot be accurately counselled on recurrence
A short-read exome panel with AI-based variant–phenotype correlation
DrSeq IRD is Nucleome’s whole-exome-sequencing-based panel for inherited retinal diseases. It combines a standard, proven sequencing workflow with an AI-powered step that links rare variants to disease phenotypes.
Validated on a real-world cohort
Developed and tested on 500 blood samples. Including relatives enables trio analysis, which helps determine how a variant is inherited.
AI correlation turns exome variants into phenotype-linked results
13 phenotypes, led by retinitis pigmentosa at 372 genes
Non-syndromic IRDs affect the eye only. Syndromic IRDs affect other tissues and organs as well — for example, Usher syndrome causes hearing loss in addition to vision loss. Numbers show the genes associated with each phenotype.
Non-syndromic IRDs
Photoreceptor dysfunction
Maculopathies
Syndromic IRDs
Other phenotypes
Genes can be associated with more than one phenotype; the comprehensive panel covers more than 500 genes in total.
Exome sequencing in a South Indian retinitis pigmentosa cohort
Retinitis pigmentosa (RP) is the most common inherited retinal disease. In a prospective study published in Ophthalmology Science in 2026, Aravind Eye Hospital, Coimbatore, used whole-exome sequencing to find the genetic cause of RP in 109 unrelated patients. The exome sequencing was performed by Nucleome Informatics.
Study at a glance
| Setting | Aravind Registry for Inherited Diseases of the Eye (ARIDE), Aravind Eye Hospital, Coimbatore |
| Participants | 109 unrelated patients (113 affected people including 4 relatives). Mean age 39.3 years (range 15 to 72); 58.7% male |
| Enrolment | Consecutive patients, regardless of ability to pay for testing (September 2024 to March 2025) |
| Clinical types | 83.5% non-syndromic RP, 9.2% syndromic RP, 6.4% atypical RP, 0.9% rod-cone dystrophy |
| Sequencing | Whole exome (Twist Exome 2.0) on the Illumina NovaSeq 6000, 2 × 150 bp, hg38. Mean on-target depth about 50 to 80×, more than 94% of target bases at 20× or more |
| Interpretation | ACMG/AMP classification; each case labelled solved, possibly solved, inconclusive or unsolved using rules set in advance |
Headline results
Key results
- 186 rare variants in 92 genes. 26 were pathogenic and 33 likely pathogenic; the other 127 (68.3%) were variants of uncertain significance.
- Four genes explained 42% of diagnoses. EYS and USH2A (7 patients each), ADGRV1 (4) and MFSD8 (3) accounted for 21 of the 50 diagnosed patients.
- Mostly recessive disease. 88% of diagnoses (44 of 50) were autosomal recessive, 8% autosomal dominant and 4% X-linked (RPGR).
- Consanguinity shaped the results. All 17 diagnosed recessive cases from consanguineous families were homozygous, as were 68% from families without reported consanguinity (P = 0.013). Yield was 51.4% vs 41.7%, a difference that was not statistically significant.
- Mostly loss-of-function variants. 76.3% of the 59 pathogenic or likely pathogenic variants were predicted to switch off the gene.
Findings worth highlighting
A regional gene spectrum
An earlier panel-based South Indian study found CERKL to be the leading gene (21%). CERKL was absent here, while ADGRV1 and MFSD8 stood out — one centre’s gene catalogue should not be assumed to hold across the region.
Recurrent and possible founder variants
MFSD8 c.1361T>C, an established South Asian founder variant, was found homozygous in 3 unrelated patients. EYS c.4321C>T and ADGRV1 c.14329C>T each recurred in 3 unrelated patients and are candidate founder alleles.
Syndromic disease can look like isolated RP
ADGRV1, linked to Usher syndrome type 2C, was the cause in 4 patients who presented with isolated RP. The authors recommend hearing tests in such cases, as the diagnosis affects counselling, monitoring and trial eligibility.
The variant-classification gap
The 68.3% share of uncertain variants reflects how poorly South Asian variants are represented in gnomAD and ClinVar. The authors propose testing relatives, depositing curated variants in ClinVar, re-analysis every 18 months and WGS for unresolved families.
Limitations noted by the authors: single centre, no systematic parental sequencing for phasing, and exome sequencing cannot detect deep intronic, repeat-expansion or many structural variants.
Source: Jaju S, Sivagnanam J, et al. Ophthalmology Science 2026;6:101341.
Designed for Indian patients and families
What sets the panel apart, from our team in Hyderabad.
Built for India
Developed and validated on an Indian cohort to close the representation gap left by global variant databases.
AI variant–phenotype correlation
An AI step links rare variants to IRD phenotypes, focusing attention on the variants most likely to explain the condition.
Trio analysis
Testing relatives resolves autosomal recessive, autosomal dominant and X-linked inheritance for clearer family counselling.
Flexible panel choice
Choose a phenotype-specific panel or the comprehensive IRD panel covering more than 500 genes.
Proven sequencing workflow
Whole exomes on the Illumina NovaSeq 6000, aligned to hg38 and annotated against ClinVar, dbSNP and ExAC.
Patent application filed
Patent application no. 202441085453 filed, with the freedom-to-operate assessment received.
Frequently asked, in plain language
For clinicians, patients and families considering IRD genetic testing.
basicWhat are inherited retinal diseases?
basicWhy does a genetic diagnosis matter for IRDs?
basicWhat is the difference between syndromic and non-syndromic IRDs?
intermediateCan I order a panel for one phenotype, or do I need the full panel?
intermediateWhy do you ask for samples from relatives?
intermediateWhat does the AI step do?
advancedWhy does an India-specific approach matter?
advancedHow was the panel validated?
Key literature & sources
- Britten-Jones AC, Gocuk SA, Goh KL, Huq A, Edwards TL, Ayton LN. The diagnostic yield of next generation sequencing in inherited retinal diseases: a systematic review and meta-analysis. Am J Ophthalmol 2023;249:57–73. doi:10.1016/j.ajo.2022.12.027
- Jaju S, Sivagnanam J, et al. Whole-exome sequencing in a consanguinity-enriched South Indian retinitis pigmentosa cohort: diagnostic yield and molecular spectrum. Ophthalmology Science 2026;6:101341. doi:10.1016/j.xops.2026.101341









